BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10768838)

  • 1. Selection of an immunogenic and protective epitope of the PsaA protein of Streptococcus pneumoniae using a phage display library.
    Srivastava N; Zeiler JL; Smithson SL; Carlone GM; Ades EW; Sampson JS; Johnson SE; Kieber-Emmons T; Westerink MA
    Hybridoma; 2000 Feb; 19(1):23-31. PubMed ID: 10768838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
    Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
    Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic protein contaminants in pneumococcal vaccines.
    Yu J; Briles DE; Englund JA; Hollingshead SK; Glezen WP; Nahm MH
    J Infect Dis; 2003 Mar; 187(6):1019-23. PubMed ID: 12660950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baculovirus expression, purification and evaluation of recombinant pneumococcal surface adhesin A of Streptococcus pneumoniae.
    De BK; Sampson JS; Ades EW; Johnson SE; Stinson AR; Crook J; Tharpe JA; Huebner RC; Carlone GM
    Pathobiology; 1999; 67(3):115-22. PubMed ID: 10394131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced immunogenicity of pneumococcal surface adhesin A by genetic fusion to cytokines and evaluation of protective immunity in mice.
    Gor DO; Ding X; Li Q; Schreiber JR; Dubinsky M; Greenspan NS
    Infect Immun; 2002 Oct; 70(10):5589-95. PubMed ID: 12228286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA).
    Talkington DF; Brown BG; Tharpe JA; Koenig A; Russell H
    Microb Pathog; 1996 Jul; 21(1):17-22. PubMed ID: 8827703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae.
    Miyaji EN; Dias WO; Gamberini M; Gebara VC; Schenkman RP; Wild J; Riedl P; Reimann J; Schirmbeck R; Leite LC
    Vaccine; 2001 Dec; 20(5-6):805-12. PubMed ID: 11738744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli.
    De BK; Sampson JS; Ades EW; Huebner RC; Jue DL; Johnson SE; Espina M; Stinson AR; Briles DE; Carlone GM
    Vaccine; 2000 Mar; 18(17):1811-21. PubMed ID: 10699329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of pneumococcal carriage in mice by subcutaneous immunization with peptides from the common surface protein pneumococcal surface adhesin a.
    Johnson SE; Dykes JK; Jue DL; Sampson JS; Carlone GM; Ades EW
    J Infect Dis; 2002 Feb; 185(4):489-96. PubMed ID: 11865401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the psaA gene, coding for pneumococcal surface adhesin A, in viridans group streptococci other than Streptococcus pneumoniae.
    Jado I; Fenoll A; Casal J; Pérez A
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):895-8. PubMed ID: 11527799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do antibodies to pneumococcal surface adhesin a prevent pneumococcal involvement in acute otitis media?
    Rapola S; Kilpi T; Lahdenkari M; Takala AK; Mäkelä PH; Käyhty H
    J Infect Dis; 2001 Sep; 184(5):577-81. PubMed ID: 11494164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
    Xu JH; Dai WJ; Chen B; Fan XY
    Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunoprotective effect of combined pneumococcal endopeptidase O and pneumococcal surface adhesin A vaccines against Streptococcus pneumoniae infection].
    Zhang J; Cui YL; Jiang YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 May; 19(5):583-589. PubMed ID: 28506354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Protective Efficacy of Selected Immunodominant B-Cell Epitopes within Virulent Surface Proteins of Streptococcus pneumoniae.
    Papastamatiou T; Routsias JG; Koutsoni O; Dotsika E; Tsakris A; Spoulou V
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media.
    Rapola S; Jäntti V; Haikala R; Syrjänen R; Carlone GM; Sampson JS; Briles DE; Paton JC; Takala AK; Kilpi TM; Käyhty H
    J Infect Dis; 2000 Oct; 182(4):1146-52. PubMed ID: 10979911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction and characterization of helper T-cell epitopes from pneumococcal surface adhesin A.
    Singh R; Gupta P; Sharma PK; Ades EW; Hollingshead SK; Singh S; Lillard JW
    Immunology; 2014 Apr; 141(4):514-30. PubMed ID: 24138116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant.
    Chen X; Li B; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Zhang Y; Wu Y
    Med Microbiol Immunol; 2019 Apr; 208(2):215-226. PubMed ID: 30707297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age.
    Schmid P; Selak S; Keller M; Luhan B; Magyarics Z; Seidel S; Schlick P; Reinisch C; Lingnau K; Nagy E; Grubeck-Loebenstein B
    Vaccine; 2011 May; 29(23):3982-9. PubMed ID: 21481328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae.
    Ogunniyi AD; Folland RL; Briles DE; Hollingshead SK; Paton JC
    Infect Immun; 2000 May; 68(5):3028-33. PubMed ID: 10769009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.